- Home
- PFO vs TELA Comparison
PFO vs TELA Comparison
Compare PFO & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFO
- TELA
- Stock Information
- Founded
- PFO 1991
- TELA 2012
- Country
- PFO United States
- TELA United States
- Employees
- PFO N/A
- TELA N/A
- Industry
- PFO Finance Companies
- TELA Medical/Dental Instruments
- Sector
- PFO Finance
- TELA Health Care
- Exchange
- PFO Nasdaq
- TELA Nasdaq
- Market Cap
- PFO 118.2M
- TELA 112.5M
- IPO Year
- PFO N/A
- TELA 2019
- Fundamental
- Price
- PFO $9.13
- TELA $2.63
- Analyst Decision
- PFO
- TELA Strong Buy
- Analyst Count
- PFO 0
- TELA 4
- Target Price
- PFO N/A
- TELA $9.25
- AVG Volume (30 Days)
- PFO 31.8K
- TELA 166.5K
- Earning Date
- PFO 01-01-0001
- TELA 11-07-2024
- Dividend Yield
- PFO 6.51%
- TELA N/A
- EPS Growth
- PFO N/A
- TELA N/A
- EPS
- PFO N/A
- TELA N/A
- Revenue
- PFO N/A
- TELA $68,649,000.00
- Revenue This Year
- PFO N/A
- TELA $30.39
- Revenue Next Year
- PFO N/A
- TELA $25.51
- P/E Ratio
- PFO N/A
- TELA N/A
- Revenue Growth
- PFO N/A
- TELA 29.34
- 52 Week Low
- PFO $6.90
- TELA $2.30
- 52 Week High
- PFO $8.51
- TELA $7.84
- Technical
- Relative Strength Index (RSI)
- PFO 53.85
- TELA 37.77
- Support Level
- PFO $9.05
- TELA $2.57
- Resistance Level
- PFO $9.20
- TELA $2.88
- Average True Range (ATR)
- PFO 0.13
- TELA 0.19
- MACD
- PFO 0.01
- TELA -0.03
- Stochastic Oscillator
- PFO 82.50
- TELA 11.34
About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end investment company. Its primary investment objective is to produce high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.
About TELA TELA Bio Inc.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.